Interleukin 21: combination strategies for cancer therapy von Smyth, Mark J, Sivakumar, Pallavur V, Skak, Kresten, Kragh, Michael, Hausman, Diana

Volltext

IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism von Takaki, Rayna, Hayakawa, Yoshihiro, Nelson, Andrew, Sivakumar, Pallavur V, Hughes, Steven, Smyth, Mark J, Lanier, Lewis L

Volltext

Interleukin-21 Signaling: Functions in Cancer and Autoimmunity von DAVIS, Ian D, SKAK, Kresten, SMYTH, Mark J, KRISTJANSEN, Paul E. G, MILLER, Dennis M, SIVAKUMAR, Pallavur V

Volltext

Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models von Krejsa, Cecile M, Holly, Rick D, Heipel, Mark, Bannink, Ken M, Johnson, Rebecca, Roque, Richard, Heffernan, Jane, Hill, Julie, Chin, Lay, Wagener, Felecia, Shiota, Faith, Henderson, Katherine, Sivakumar, Pallavur V, Ren, Hong-Ping, Barahmand-Pour, Fariba, Foster, Don, Clegg, Chris, Kindsvogel, Wayne, Ponce, Rafael, Hughes, Steven D, Waggie, Kim

Volltext

A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo von Mabry, Robert, Gilbertson, Debra G., Frank, Amanda, Vu, Tuyen, Ardourel, Dan, Ostrander, Craig, Stevens, Brenda L., Julien, Susan H., Franke, Secil, Meengs, Brent, Brody, Jennifer, Presnell, Scott, Hamacher, Nels B., Lantry, Megan, Wolf, Anitra C., Bukowski, Tom, Rosler, Robert, Yen, Cindy, Anderson-Haley, Monica, Brasel, Kenneth, Pan, Qi, Franklin, Hank, Thompson, Penny, Dodds, Mike, Underwood, Sara, Peterson, Scott, Sivakumar, Pallavur V., Snavely, Mark

Volltext

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells von Goldrath, Ananda W, Sivakumar, Pallavur V, Glaccum, Moira, Kennedy, Mary K, Bevan, Michael J, Benoist, Christophe, Mathis, Diane, Butz, Eric A

Volltext

Comparison of Vascular Leak Syndrome in Mice Treated with IL21 or IL2 von Sivakumar, Pallavur V, Garcia, Richard, Waggie, Kimberly S, Anderson-Haley, Monica, Nelson, Andrew, Hughes, Steven D

Volltext

Endogenous IL-21 Restricts CD8+ T Cell Expansion and Is not Required for Tumor Immunity von Sondergaard, Henrik, Coquet, Jonathan M, Uldrich, Adam P, McLaughlin, Nicole, Godfrey, Dale I, Sivakumar, Pallavur V, Skak, Kresten, Smyth, Mark J

Volltext

Interleukin‐21 is a T‐helper cytokine that regulates humoral immunity and cell‐mediated anti‐tumour responses von Sivakumar, Pallavur V., Foster, Donald C., Clegg, Christopher H.

Volltext

Interleukin 21 enhances antibody-mediated tumor rejection von Smyth, Mark J, Teng, Michele W L, Sharkey, Janelle, Westwood, Jennifer A, Haynes, Nicole M, Yagita, Hideo, Takeda, Kazuyoshi, Sivakumar, Pallavur V, Kershaw, Michael H

Volltext

Erratum: Interleukin 21: combination strategies for cancer therapy von Skak, Kresten, Kragh, Michael, Hausman, Diana, Smyth, Mark J., Sivakumar, Pallavur V.

Volltext

Interleukin 21: combination strategies for cancer therapy von Skak, Kresten, Kragh, Michael, Hausman, Diana, Smyth, Mark J, Sivakumar, Pallavur V

Volltext

Fetal and neonatal NK1.1 + Ly‐49 − cells can distinguish between major histocompatibility complex class I hi and class I lo target cells: Evidence for a Ly‐49‐independent negative... von Sivakumar, Pallavur V., Bennett, Michael, Kumar, Vinay

Volltext

Fetal and neonatal NK1.1+ Ly-49- cells can distinguish between major histocompatibility complex class I(hi) and class I(lo) target cells: evidence for a Ly-49-independent negative... von Sivakumar, P V, Bennett, M, Kumar, V

Volltext

Interleukin-29 Mediates Potent Anti-Tumor Activity in the RenCa Model of Renal Cell Carcinoma von Sivakumar, Pallavur V, Doyle, Sean E, Shiota, Faith, Yao, Lena, Storey, Harold, Khuu-Duong, Kien, Liu, Hong Y, Chan, Chung, Kindsvogel, Wayne, Klucher, Kevin M, Clegg, Christopher H

Volltext

Interleukin 21: combination strategies for cancer therapy von Skak, Kresten, Kragh, Michael, Hausman, Diana, Smyth, Mark J, Sivakumar, Pallavur V

Volltext

Fetal and neonatal NK1.1+ Ly‐49− cells can distinguish between major histocompatibility complex class Ihi and class Ilo target cells: Evidence for a Ly‐49‐independent negative sign... von Sivakumar, Pallavur V., Bennett, Michael, Kumar, Vinay

Volltext

IL-18 is a primary mediator of inflammation associated with DSS-induced colitis: Blocking IL-18 prevents intestinal damage von Sivakumar, Pallavur V., Westrich, Gina M., Kanaly, Suzanne, Sims, John, Derry, Jonathan, Viney, Joanne L.

Volltext

ANTI-HUMAN IL-21 ANTIBODIES von JASPERS Stephen R, SIVAKUMAR Pallavur V

Volltext bestellen

A dual-targeting PDGFRbeta/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo von Mabry, Robert, Gilbertson, Debra G, Frank, Amanda, Vu, Tuyen, Ardourel, Dan, Ostrander, Craig, Stevens, Brenda, Julien, Susan, Franke, Secil, Meengs, Brent, Brody, Jennifer, Presnell, Scott, Hamacher, Nels B, Lantry, Megan, Wolf, Anitra, Bukowski, Tom, Rosler, Robert, Yen, Cindy, Anderson-Haley, Monica, Brasel, Kenneth, Pan, Qi, Franklin, Hank, Thompson, Penny, Dodds, Mike, Underwood, Sara, Peterson, Scott, Sivakumar, Pallavur V, Snavely, Mark

Volltext